Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment

Brittany N Dugger1, Kathryn Davis2, Michael Malek-Ahmadi3

  • 1Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, 10515 W. Santa Fe Dr., Sun City, AZ, 85351, USA. Brittany.dugger@bannerhealth.com.

BMC Neurology
|August 21, 2015
PubMed
Abstract

Insights

This study compared the neuropathology of amnestic (aMCI) and nonamnestic (naMCI) mild cognitive impairment. While both showed similar overall pathology, naMCI had more Lewy bodies and aMCI had more neurofibrillary tangles in specific brain regions.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Cognitive Impairment

Background:

  • Mild cognitive impairment (MCI) research often compares to normal aging or Alzheimer's disease (AD).
  • Limited studies directly compare the comprehensive neuropathology of amnestic (aMCI) and nonamnestic (naMCI) MCI.

Purpose of the Study:

  • To conduct a comprehensive neuropathological comparison between aMCI and naMCI.
  • To identify distinct pathological markers differentiating aMCI and naMCI.

Main Methods:

  • Utilized data from the Brain and Body Donation Program, a longitudinal clinicopathological study.
  • Analyzed neuropathological lesions including plaques, neurofibrillary tangles (NFTs), Lewy bodies (LBs), infarcts, cerebral white matter rarefaction (CWMR), and cerebral amyloid angiopathy (CAA).
  • Assessed concurrent diagnoses such as Parkinson's disease (PD) and AD.

Main Results:

  • Compared 34 aMCI and 15 naMCI subjects; aMCI subjects were older at death.
  • naMCI cases showed higher temporal lobe Lewy body densities (p=0.04).
  • aMCI cases showed a trend towards increased parietal and temporal NFTs (p=0.07), significant after age adjustment.
  • Executive dysfunction in MCI correlated with increased CAA and CWMR.
  • No significant differences in AD neuropathology; PD co-occurrence differed (24% aMCI vs. 47% naMCI).

Conclusions:

  • No single pathology strongly distinguished aMCI and naMCI due to heterogeneity.
  • Findings suggest potential regional differences: naMCI may show more Lewy bodies, and aMCI may show more neurofibrillary tangles.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
849
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
869
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
709